Zoeken op ZonMw
Zoeken op de website
Filters
899
resultaten
- Afbeelding
Read which studies on ZonMw funds microplastics and nanoplastics. More knowledge is needed about the increasing health risks of microplastics. - Afbeelding
Cancer is one of the biggest health challenges of our time. It is the leading cause of death in the Netherlands and affects as many as one in two people. Cancer is not a single disease; there are more than 100 different types of cancer. To truly understand cancer, ZonMw is collaborating with the Oncode Institute - Afbeelding
The Rubicon programme allows researchers who have recently gained their PhD to acquire experience at a foreign knowledge institute. That is an important launchpad to an academic career. - Afbeelding
Antimicrobial resistance affects human and animal health because it causes untreatable infections. Read which research ZonMw is funding. - Afbeelding
Het PharmaNL Shared Development Infrastructure (SDI) programma richt zich op het opzetten van geavanceerde infrastructuur voor gedeeld gebruik door farmaceutische start-ups, scale-ups en academische onderzoeksgroepen. - Afbeelding
Het PharmaNL programma omvat de twee programmalijnen Shared Development Infrastructure (SDI) en Human Capital Growth (HCG), die bijdragen aan succesvolle medicijninnovaties. - Afbeelding
Post-COVID, ook wel Long-COVID genoemd, verwijst naar de aanhoudende gezondheidsproblemen die sommige mensen ervaren na herstel van een besmetting met SARS-CoV-2, het virus dat de ziekte COVID-19 veroorzaakt. - Afbeelding
The Vici target group consists of researchers in the stage of consolidation and further development of leadership/research group. The financing amounts to a maximum of 1,500,000 euros. Researchers who obtained their PhD no more than 15 years ago, with or without permanent employment, from home or abroad can submit. - Afbeelding
Vidi enables researchers, who have been conducting research at postdoc level for a number of years, to develop their own innovative line of research and to appoint one or more researchers. The funding amounts to a maximum of €850,000. Researchers who received their PhD no more than eight years ago, with or without permanent employment, can apply.
